Relative Value Partners Group, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 82 filers reported holding SEELOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
Relative Value Partners Group, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$17,925
-13.6%
15,000
-50.0%
0.00%0.0%
Q1 2023$20,736
+103.6%
30,000
+100.0%
0.00%0.0%
Q4 2022$10,18515,0000.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,908,725$5,056,0000.66%
Uniplan Investment Counsel, Inc. 2,485,327$2,559,0000.20%
Oasis Management Co Ltd. 850,000$876,0000.15%
AdvisorShares Investments LLC 470,151$484,0000.13%
1492 Capital Management LLC 99,819$103,0000.07%
Sovereign Financial Group, Inc. 75,000$77,0000.03%
ASSET MANAGEMENT CORP /IL/ /ADV 45,500$47,0000.03%
MAI Capital Management 1,230,810$1,268,0000.02%
GSA CAPITAL PARTNERS LLP 137,266$141,0000.02%
FORTEM FINANCIAL GROUP, LLC 20,000$21,0000.02%
View complete list of SEELOS THERAPEUTICS INC shareholders